Cannabinoid – CFN Media

Chilco River Holdings Acquires Colorado Corporation American Hemp Brands

CHATSWORTH, CA / ACCESSWIRE / November 7, 2023 / Chilco River Holdings, Inc.…

Ryan Allway
November 7, 2023

FloraWorks Announces Scientific Breakthrough in Natural Sleep Aids: First-Ever Double-Blind, Randomized, Placebo-Controlled Clinical Trial Discovers CBN Effective for Sleep

Independently Conducted Trial by Radicle Science Finds Florworks’s Flagship TruCBN; Showed a…

Ryan Allway
June 28, 2023

Top News

Anebulo Pharmaceuticals Announces Completion of Dosing and Preliminary Data from Part B of its Phase 2 Study of ANEB-001 for Acute Cannabinoid Intoxication

AUSTIN, Texas, January 09, 2023–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical…

Ryan Allway
January 9, 2023

Top News

Hempacco Welcomes Miki Stephens to Its Board of Directors

Stephens brings deep industry and corporate governance experience to Hempacco San Diego,…

Ryan Allway
December 6, 2022

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

Cardiol Wraps Up One Phase 2 Trial, Preparing for Phase 3

Small pharmaceutical developers have been responsible for the clinical trials of the…

Robin Lefferts
September 17, 2024

Lithium South Development Announces Completion of Phase I Environmental Baseline Study and Progress on Phases II and III

VANCOUVER, BC, Sept. 12, 2024 /CNW/ — Lithium South Development…

Ryan Allway
September 12, 2024

Healthcare Stocks

Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024

Full clinical data will be reported in an oral presentation at the…

Ryan Allway
September 10, 2024

Aduro Enters Another Multi-Billion Dollar Market

For Aduro Clean Technologies, Inc. (CSE: ACT) (OTCQB: ACTHD) (FSE: 9D5), recycling…

Ryan Allway
September 5, 2024